Successful thrombolytic therapy for acute and chronic occlusion of polytef vascular grafts.
Thrombolytic therapy for thrombosed arterial bypass grafts has received little attention in the medical literature. We carried out successful thrombolysis in occluded polytef arterial bypass grafts. A femoral-femoral artery crossover graft had been occluded 13 days, and a femoral-popliteal artery bypass graft had been occluded three months. No surgical intervention was required. Follow-up showed continued patency nine months following thrombolytic therapy. Long-term oral anticoagulation seems indicated. Also, data suggest thrombus in polytef grafts may be particularly susceptible to lyses. Thrombolytic therapy should play an increasing role in vascular surgery.
D001807:Blood Vessel Prosthesis; D005263:Femoral Artery / Q000601:surgery; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011138:Polytetrafluoroethylene; D011150:Popliteal Artery / Q000601:surgery; D011183:Postoperative Complications / Q000188:drug therapy; D013300:Streptokinase / Q000627:therapeutic use*; D013927:Thrombosis / Q000188:drug therapy
D005343:Fibrinolytic Agents; D011138:Polytetrafluoroethylene; D013300:Streptokinase